Randomized, double-blind, placebo-controlled phase II study of AMG 386 in combination with cisplatin and capecitabine (CX) in patients (pts) with metastatic gastroesophageal adenocarcinoma
Date issued
2011Journal title
Journal of Thoracic Oncology
Type of content
Publicación de congreso